Risk factors and clinical outcome of breakthrough yeasts bloodstream infections in patients with hematological malignancies in the era of new antifungal agents

Kim S. H.; Choi J.; Cho S. Y.; Lee D.; Park S. H.; Choi S. M.; Yoo J.

首页> 外文期刊>Mycoses: Diagnosis, therapy and prophylaxis of fungal diseases >Risk factors and clinical outcome of breakthrough yeasts bloodstream infections in patients with hematological malignancies in the era of new antifungal agents

【24h】

Risk factors and clinical outcome of breakthrough yeasts bloodstream infections in patients with hematological malignancies in the era of new antifungal agents

机译：新型抗真菌药时代血液恶性肿瘤患者突破性酵母菌血液感染的危险因素和临床结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Mycoses: Diagnosis, therapy and prophylaxis of fungal diseases》 |2015年第4期|共2页
作者
Kim S. H.; Choi J.; Cho S. Y.; Lee D.; Park S. H.; Choi S. M.; Yoo J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学微生物学（病原细菌学、病原微生物学）;
关键词

相似文献

外文文献
中文文献
专利

1. Risk factors and clinical outcomes of breakthrough yeast bloodstream infections in patients with hematological malignancies in the era of newer antifungal agents [J] . Kim Si-Hyun, Choi Jae-Ki, Cho Sung-Yeon, Medical mycology: official publication of the International Society for Human and Animal Mycology . 2018,第2期

机译：初期抗真菌剂时代血液恶性肿瘤患者突破酵母血流感染的危险因素及临床结果
2. Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes [J] . Herc Erica S., Kauffman Carol A., Marini Bernard L., Leukemia and lymphoma . 2017,第11a12期

机译：达摩霉素无精情霉素抗性肠球菌患者血液血液血液血液血清血液血清感染患者血液恶性肿瘤：危险因素和结果
3. Analysis of Risk Factors and Clinical Indicators in Bloodstream Infections Among Patients with Hematological Malignancy [J] . Yating Ma, Shijian Wang, Ming Yang, Cancer Management and Research . 2020,第3期

机译：血液恶性肿瘤患者血流感染危险因素及临床指标分析
4. Data Mining Analysis of Relationship Between BloodStream Infection and Clinical Background in Patients Undergoing Lactobacillus Therapy [C] . Kimiko Matsuoka, Shigeki Yokoyama, Kunitomo Watanabe, New Frontiers in Artificial Intelligence . 2007

机译：乳酸菌治疗患者血流感染与临床背景关系的数据挖掘分析
5. Is there a difference in risk factors and patient outcomes in patients with catheter-related bloodstream infections caused by vancomycin-resistant and vancomycin-sensitive Enterococcus in a medical intensive care unit? [D] . Arndt, Jennifer L. 2007

机译：在重症监护病房中因万古霉素耐药和对万古霉素敏感的肠球菌引起的导管相关性血流感染患者的危险因素和患者预后是否存在差异？
6. Risk factors and clinical outcomes of breakthrough yeast bloodstream infections in patients with hematological malignancies in the era of newer antifungal agents [O] . Si-Hyun Kim, Jae-Ki Choi, Sung-Yeon Cho, -1

机译：新型抗真菌药时代血液恶性肿瘤患者突破性酵母菌血流感染的危险因素和临床结果
7. Risk factors and clinical outcomes of breakthrough yeast bloodstream infections in patients with hematological malignancies in the era of newer antifungal agents [O] . Si-Hyun Kim, Jae-Ki Choi, Sung-Yeon Cho, 2017

机译：初期抗真菌剂时代血液恶性肿瘤患者突破酵母血流感染的危险因素及临床结果

Risk factors and clinical outcome of breakthrough yeasts bloodstream infections in patients with hematological malignancies in the era of new antifungal agents

著录项

相似文献

相关主题

期刊订阅